THE COMPANY Cumberland Pharmaceuticals Inc. ("Cumberland," the "Company," or as used in the context of "we," "us" or "our"), is a specialty pharmaceutical company focused on the acquisition, development and commercialization of branded prescription pharmaceuticals. We are dedicated to our mission of working together to provide unique products that improve the quality of patient care. Our primary target markets are hospital acute care, gastroenterology and oncology. These medical specialties are ...
Q2 FY2026 — expected 2026-08-05
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2026-03-09 | 2025-12-31 | 0001087294-26-000020 | EDGAR | 62K words |
| 2025-03-07 | 2024-12-31 | 0001628280-25-011366 | EDGAR | — |
| 2024-03-13 | 2023-12-31 | 0001628280-24-010725 | EDGAR | — |
| 2023-03-13 | 2022-12-31 | 0001628280-23-007727 | EDGAR | — |
| 2022-03-11 | 2021-12-31 | 0001628280-22-005942 | EDGAR | — |
| 2021-03-12 | 2020-12-31 | 0001628280-21-004654 | EDGAR | — |
| 2020-03-20 | 2019-12-31 | 0001628280-20-003880 | EDGAR | — |
| 2019-03-12 | 2018-12-31 | 0001628280-19-002785 | EDGAR | — |
| 2018-03-09 | 2017-12-31 | 0001628280-18-003034 | EDGAR | — |
| 2017-03-13 | 2016-12-31 | 0001628280-17-002485 | EDGAR | — |
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2026-08-07 | 2026-06-30 | 0001087294-26-000062 | EDGAR | — |
| 2025-11-07 | 2025-09-30 | 0001087294-25-000020 | EDGAR | 17K words |
| 2025-08-08 | 2025-06-30 | 0001628280-25-039326 | EDGAR | — |
| 2025-05-09 | 2025-03-31 | 0001628280-25-024342 | EDGAR | — |
| 2024-11-08 | 2024-09-30 | 0001628280-24-046730 | EDGAR | — |
| 2024-08-09 | 2024-06-30 | 0001628280-24-036529 | EDGAR | — |
| 2024-05-10 | 2024-03-31 | 0001628280-24-022658 | EDGAR | — |
| 2023-11-13 | 2023-09-30 | 0001628280-23-038418 | EDGAR | — |
| 2023-08-11 | 2023-06-30 | 0001628280-23-029112 | EDGAR | — |
| 2023-05-12 | 2023-03-31 | 0001628280-23-017951 | EDGAR | — |
| 2022-11-14 | 2022-09-30 | 0001628280-22-029906 | EDGAR | — |
| 2022-08-12 | 2022-06-30 | 0001628280-22-022735 | EDGAR | — |
| Filed | Accession | Source | Full Text |
|---|---|---|---|
| 2026-08-04 | 0001087294-26-000058 | EDGAR | — |
| 2026-07-13 | 0001087294-26-000055 | EDGAR | — |
| 2026-03-03 | 0001087294-26-000015 | EDGAR | 6K words |
| 2026-02-04 | 0001087294-26-000011 | EDGAR | — |
| 2025-11-24 | 0001087294-25-000023 | EDGAR | — |
| 2025-11-04 | 0001087294-25-000017 | EDGAR | — |
| 2025-10-21 | 0001087294-25-000012 | EDGAR | — |
| 2025-08-05 | 0001628280-25-037923 | EDGAR | — |
| 2025-05-06 | 0001628280-25-022753 | EDGAR | — |
| 2025-04-28 | 0001628280-25-020222 | EDGAR | — |
335 total filings indexed. 303 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR
| CIK | 0001087294 |
| Ticker | CPIX |
| Exchange | Nasdaq |
| SIC | 2834: Pharmaceutical Preparations |
| Incorporated | TN |
| Website | https://www.cumberlandpharma.com |
| Listed | 2009-08-11 |
This is a static snapshot. For live, structured JSON with cryptographic provenance chain:
MCP (recommended for AI): claude mcp add origin --transport http https://origin.rootz.global/mcp
Try it — paste this into your AI:
Works in ChatGPT, Claude, Gemini, or any AI. Free, structured, cryptographically signed — ~500 tokens vs 130,000 scraping an IR site.
claude mcp add origin --transport http https://origin.rootz.global/mcpGET https://origin.rootz.global/api/company/CPIX (~200 tokens, structured JSON with cryptographic provenance)